Skip to main content
. 2023 Mar 10;14:1307. doi: 10.1038/s41467-023-37020-y

Fig. 9. The tumor suppression of mRNA nano-lantern in an orthotropic cecal injection model.

Fig. 9

a Systematic schedule of Smade4 mRNA nano-lantern administration in the orthotopic model of SW480-Luc cells. Created with BioRender.com. b Representative bioluminescence imaging of tumor burden and fluorescence imaging of Cy5-mRNA nano-lantern in tumor-bearing nude mice. c Ex vivo images of the xenograft tumors at the endpoint. d IL-6 and INF-β levels in peripheral blood of tumor bearing mice after 6 h post-intraperitoneal injection of different formulations (n = 4 mice/group). e Representative IHC staining for Smad4 in tumor tissues from 4 mice/group. Scale bar: 100 μm. f Representative H&E staining of organs and tumor tissues in the tumor-bearing mice from 4 mice/group. Scale bar: 100 μm. g Representative western blot analysis of Smad4, MYC, VEGFC, and CXCL5 expression in orthotopic tumors from 4 independent experiments. Data are presented as the mean ± SEM. Statistical differences were assessed using one-way ANOVA with Bonferroni multiple comparisons test. *p < 0.05, **p < 0.01, ***p < 0.001. Source data are provided as a Source Data file.